• Josep Carreras Leukaemia Research Institute - BIYSC

Josep Carreras Leukaemia Research Institute

The Josep Carreras Leukaemia Research Institute is a non-profit research institute based in Barcelona, dedicated to biomedical research and personalized medicine in leukemia and other malignant blood diseases.

It was launched in 2010 by the Josep Carreras Foundation, and the Catalan Government, and its current director is Professor Manel Esteller.

The institute is home to 38 research groups conducting excellent research into the basic, epidemiological, preventive, clinical and translational aspects of leukemia and other hematological malignancies.

Our efforts are directed towards identifying new therapeutic targets and developing effective treatments through cutting-edge research.

Josep Carreras Leukaemia Research Institute
Excellence and recognition awards
  • The Josep Carreras Leukaemia Research Institute has been awarded an MSCA COFUND Doctoral Programme, to boost training and career development for PhD students.
  • The Institute has 3 ICREA Research Professors among its Principal Investigators (Dr. Esteller, Dr. Menéndez and Dr. Graupera)
  • Our Human Resources Unit has been awarded the HR Excellence in Research Award by the European Commission.
  • The Josep Carreras Institute is a CERCA Centre of excellence by the Generalitat de Catalunya (Catalan Government).
Director of the center

Manel Esteller Badosa

  • M.D., Ph.D from the Universitat de Barcelona and researcher at Johns Hopkins, where his work was decisive in establishing promoter hypermethylation of tumor suppressor genes.
  • Leader of the CNIO Cancer Epigenetics Laboratory and the Director of the Cancer Epigenetics and Biology Program in Barcelona.
  • Director of the Josep Carreras Leukaemia Research Institute, Chairman of Genetics at the University of Barcelona and ICREA Research Professor.
  • His research focuses in the establishment of the cancer epigenome. He is a highly cited researcher and has received prestigious recognitions.
Renowned researcher

Pablo Menéndez

  • PhD in Biochemistry at the Department of Medicine in the University of Salamanca (Spain).
  • Postdoctoral training in stem cell biology at Mick Bhatia Laboratory (Canada) and in childhood leukemia at Mel Greaves Laboratory (UK).
  • Director of the Andalusian Stem Cell Bank (Spain) and Principal Investigator at GENyO (Spain).
  • ICREA Research Professor and Research Director of The Josep Carreras Leukemia Research Institute-Campus Clinic-UB, in Barcelona (Spain).
  • Leader in the field of childhood leukemia and world pioneer in the development of next-generation CAR-T cell therapies.
The project

Multi-omics in the fight against leukemia

Leukemia is a complex disease and, we must combine different approaches to have the full representation of what is happening in a given patient. In this course, the participants will have the opportunity to act as a member of our multidisciplinary scientific community and analyze real world samples from the genetics, epigenetics and genomics perspective, to predict the future development of the disease according to its particular features, and advice the best possible treatment.

 

More about the project